Sign ITPC’s petition to Gilead A recent decision by India’s Patent Office rejecting one of Gilead’s key patents for sofosbuvir is an important step for treatment activists. But Gilead is using every trick in the book to get the decision reversed, including lobbying the Indian Government. Sign our petition today to expand Hep C treatment!
News summary On November 24-28, 2014, the International Treatment Preparedness Coalition (ITPC) and the AIDS and Rights Alliance for Southern Africa (ARASA) held a joint workshop training, titled Community Involvement in Access to Affordable HIV Treatment: Focus on the Influence of Intellectual Property & Free Trade Agreements, at the Aviator Hotel in Johannesburg, South Africa. […]
In 2013, the International Treatment Preparedness Coalition (ITPC), through Bridging the Gaps, supported KeNPUD with a small grant to grow their organization. Mid-way through their ITPC grant, KeNPUD has conducted 15 advocacy actions, conseled 85 people, and held HIV education workshops for over 200 people. They continue to do health outreach to mobilize people to […]
News summary The report, “ Global Action with Local Impact: Why Advocacy Matters ,” details strategies used and outcomes achieved by ITPC and our other global network partners focused on key populations under the Bridging the Gaps programme. The report examines the role of international advocacy in addressing HIV among key populations, including people living […]
In July 2014, 23 community leaders came together at the Bellagio Centre, Italy for a three day meeting to assess the state of the HIV/AIDS movement. The meeting resulted in this Call to Action. The Bellagio meeting brought together a diverse group of academics, health practitioners, activists and policy makers, including HIV and human rights […]